Literature DB >> 2964478

Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines.

J L Liesveld1, C N Abboud, R J Looney, D H Ryan, J K Brennan.   

Abstract

Three classes of FcR have been defined on human myeloid cells by their reactivity with mAb; FcRI (mAb 32); FcRII (mAb IV3); and FcRIII (mAb 3G8). We have quantitated the expression of each FcR on human myeloid leukemia cells and cell lines (KG-1, HL-60, U937, and K562). Detailed analysis of FcR surface expression is provided for the U937 cell line after exposure to CSF and cytokines. Increased expression of FcRI and FcRII occurred at 72 h in cells exposed to GCT or Mo cell line-conditioned medium as well as to medium from PHA-treated mononuclear cells. The augmentation of FcRII required protein synthesis and was diminished by a neutralizing antibody to granulocyte-macrophage CSF. We also show that fractions containing natural granulocyte CSF or granulocyte-macrophage CSF as well as r-granulocyte and r-granulocyte-macrophage CSF are capable of inducing FcRII on these cells, whereas other cytokines such as IL-1 and IL-2, TNF-alpha, INF-gamma and macrophages CSF failed to do so.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964478

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Phenotypic analysis of functionally associated molecules on peripheral blood and synovial fluid monocytes from arthritis patients.

Authors:  S J Gadd; T Felzmann; O Majdic; D Maurer; P Petera; W J Chen; J Smolen; W Knapp
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 2.  The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation.

Authors:  J Auwerx
Journal:  Experientia       Date:  1991-01-15

3.  Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).

Authors:  G Masucci; P Ragnhammar; P Wersäll; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 4.  Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors.

Authors:  P Ragnhammar
Journal:  Med Oncol       Date:  1996-09       Impact factor: 3.064

5.  Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils.

Authors:  A M Buckle; Y Jayaram; N Hogg
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.

Authors:  P Ragnhammar; G Masucci; J E Frödin; A L Hjelm; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 7.  Contributions of mesangial cells to glomerular immune functions.

Authors:  D Schlondorff; T Mori
Journal:  Klin Wochenschr       Date:  1990-11-16

8.  Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.

Authors:  J B Allen; H L Wong; P M Guyre; G L Simon; S M Wahl
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults.

Authors:  K D Fairchild; R G Hudson; S D Douglas; S E McKenzie; R A Polin
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

10.  Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor.

Authors:  P Chien; R A Pixley; L G Stumpo; R W Colman; A D Schreiber
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.